Keywords: protein, thera, starts, juvenile, ra, study, therapeutics

Protein Thera starts juvenile RA study

Article | 13 July 2001

Print This

Protein Therapeutics has started a Phase II trial of its oral humangammaglobulin product, IgPO, in patients with severe juvenile rheumatoid ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in